tetano
Editor, Senior Moderator
Int J Inflam. 2013;2013:151028. Epub 2013 Aug 27.
Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold.
Keppel Hesselink JM, de Boer T, Witkamp RF.
Source
Faculty of Medicine, University Witten/Herdecke, Alfred-Herrhausen-Stra?e 50, 58448 Witten, Germany.
Abstract
Palmitoylethanolamide (PEA) is a food component known since 1957. PEA is synthesized and metabolized in animal cells via a number of enzymes and exerts a multitude of physiological functions related to metabolic homeostasis. Research on PEA has been conducted for more than 50 years, and over 350 papers are referenced in PubMed describing the physiological properties of this endogenous modulator and its pharmacological and therapeutical profile. The major focus of PEA research, since the work of the Nobel laureate Levi-Montalcini in 1993, has been neuropathic pain states and mast cell related disorders. However, it is less known that 6 clinical trials in a total of nearly 4000 people were performed and published last century, specifically studying PEA as a therapy for influenza and the common cold. This was done before Levi-Montalcini's clarification of PEA's mechanism of action, analyzing the role of PEA as an anti-inflammatory agent. We will review in depth these studies, as the results support the effectiveness and safety of PEA in flu and respiratory infections.
PMID:
24066256
[PubMed - as supplied by publisher]
PMCID:
PMC3771453
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/24066256
Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold.
Keppel Hesselink JM, de Boer T, Witkamp RF.
Source
Faculty of Medicine, University Witten/Herdecke, Alfred-Herrhausen-Stra?e 50, 58448 Witten, Germany.
Abstract
Palmitoylethanolamide (PEA) is a food component known since 1957. PEA is synthesized and metabolized in animal cells via a number of enzymes and exerts a multitude of physiological functions related to metabolic homeostasis. Research on PEA has been conducted for more than 50 years, and over 350 papers are referenced in PubMed describing the physiological properties of this endogenous modulator and its pharmacological and therapeutical profile. The major focus of PEA research, since the work of the Nobel laureate Levi-Montalcini in 1993, has been neuropathic pain states and mast cell related disorders. However, it is less known that 6 clinical trials in a total of nearly 4000 people were performed and published last century, specifically studying PEA as a therapy for influenza and the common cold. This was done before Levi-Montalcini's clarification of PEA's mechanism of action, analyzing the role of PEA as an anti-inflammatory agent. We will review in depth these studies, as the results support the effectiveness and safety of PEA in flu and respiratory infections.
PMID:
24066256
[PubMed - as supplied by publisher]
PMCID:
PMC3771453
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/24066256